Professor Rinaldo Bellomo AO MBBS MD FRACP FCICM FAHMS

Rinaldo Bellomo is a Professor of Intensive Care Medicine, University of Melbourne, Melbourne, Australia; Professor, Faculty of Medicine, Monash University, Melbourne Australia; Honorary Professorial Fellow, Faculty of Medicine, The University of NSW, Sydney, Australia; Honorary Professorial Fellow, The George Institute, Sydney, Australia; Honorary Fellow, Florey Institute of Physiology, Melbourne, Australia.

In 2018, he was awarded an Officer of the Order of Australia for distinguished service to intensive care medicine as a biomedical scientist and researcher, through infrastructure and systems development to manage the critically ill, and as an author.

In 2021, Professors Rinaldo Bellomo and Jamie Cooper were jointly awarded the GSK Award for Research Excellence (ARE) in recognition of their global leadership and innovative research in critical care medicine that has helped transform approaches to treatment of critically ill patients worldwide. The GSK ARE is one of the most prestigious awards available to the Australian medical research community. 

Professor Bellomo is the Director of Intensive Care Research and Staff Specialist in Intensive Care at Austin Health; Senior Research Advisor and Staff Specialist in Intensive Care at the Department of Intensive Care, Royal Melbourne Hospital, Visiting Staff Specialist in Intensive Care at Warringal Private Hospital in Melbourne and previous Head and now member of the Executive of the Department of Critical Care, The University of Melbourne.

He is Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) - a methods centre (established with a National Health and Medical Research Council (NHMRC) Enabling Grant) for investigator-initiated clinical research that supports >15 staff, >10 PhD candidates, and research programs in traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics. He is a NHMRC Practitioner Fellow and was Foundation Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG).

Each year for the past 7 years (2014-2021), Professor Bellomo has been named one of the world's most influential scientific minds of our time. Clarivate Analytics publishes "The world's most influential scientific minds" based on its analysis of data over the previous 11 years using Web of Science and InCites platforms to determine which researchers have produced work that is most frequently acknowledged by peers. Prof Bellomo is one of the researchers identified as "influencing the future direction of their field, and of the world", "on the cutting edge of their field" and "publishing work that their peers recognize as vital to the advancement of their science". He is also the recipient of a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award.

In 2015, Professor Bellomo became the first ANZ biomedical researcher to have more than 1,000 papers in Scopus. He has also written more than 152 book chapters and edited 13 books in the field of intensive care medicine. As at October 2021, in the Scopus database, he had >1,812 publications, an h index of 137, and total lifetime citations of >100,000 and a yearly citation rate over the past 5 years of >9,000. He is the most published and most cited medical researcher in the history of Australian medicine. He is the Editor-in-Chief of the journal Critical Care and Resuscitation.

Professor Bellomo has been Chief Investigator in many successful grant applications. Over the past 10 years, he has been heavily involved in the design, execution, supervision and publication of several large randomised controlled trials published in The Lancet and the New England Journal of Medicine (NEJM) for >30,000 intensive care unit (ICU) patients randomised.

Publications in PubMed